Mercator Medical S.A.

DB:MM2 Stock Report

Market Cap: €106.8m

Mercator Medical Valuation

Is MM2 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MM2 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: MM2 (€10.76) is trading below our estimate of fair value (€10.88)

Significantly Below Fair Value: MM2 is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MM2?

Key metric: As MM2 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for MM2. This is calculated by dividing MM2's market cap by their current revenue.
What is MM2's PS Ratio?
PS Ratio0.9x
Saleszł488.78m
Market Capzł463.12m

Price to Sales Ratio vs Peers

How does MM2's PS Ratio compare to its peers?

The above table shows the PS ratio for MM2 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2.7x
PHH2 Paul Hartmann
0.3xn/a€742.3m
PUS PULSION Medical Systems
3.8xn/a€134.4m
NN6 NanoRepro
5.5xn/a€19.6m
SBS Stratec
1.3x7.7%€321.5m
MM2 Mercator Medical
0.9xn/a€463.1m

Price-To-Sales vs Peers: MM2 is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (2.7x).

Price to Sales Ratio vs Industry

How does MM2's PS Ratio compare vs other companies in the DE Medical Equipment Industry?

4 CompaniesPrice / SalesEstimated GrowthMarket Cap
DRW3 Drägerwerk KGaA
0.2x4.2%US$828.96m
PHH2 Paul Hartmann
0.3xn/aUS$773.00m
U4W0 Quotient
0.07xn/aUS$2.78m
MF6 MagForce
0.3xn/aUS$404.27k
No more companies available in this PS range
MM2 0.9xIndustry Avg. 3.4xNo. of Companies4PS01.63.24.86.48+
4 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: MM2 is good value based on its Price-To-Sales Ratio (0.9x) compared to the European Medical Equipment industry average (3.4x).

Price to Sales Ratio vs Fair Ratio

What is MM2's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MM2 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate MM2's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

LNA Santé

€244.4m

Engages in the management and operation of health establishments.

2N3

€23.25

7D

-5.5%

1Y

18.9%

Shandong Weigao Group Medical Polymer

HK$20.1b

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.

UK2

HK$0.52

7D

-8.8%

1Y

-37.3%

Top Glove Corporation Bhd

RM 7.8b

An investment holding company, manufactures, trades in, and sells gloves in Malaysia, Thailand, the People’s Republic of China, and internationally.

5OU

RM 0.98

7D

0.5%

1Y

-82.5%